Literature DB >> 24458364

Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Shibing Yang1, Charles B Eaton, Juan Lu, Kate L Lapane.   

Abstract

PURPOSE: We systematically reviewed pharmacoepidemiologic studies published in 2012 that used inverse probability weighted (IPW) estimation of marginal structural models (MSM) to estimate the effect from a time-varying treatment.
METHODS: Potential studies were retrieved through a citation search within Web of Science and a keyword search within PubMed. Eligibility of retrieved studies was independently assessed by at least two reviewers. One reviewer performed data extraction, and a senior epidemiologist confirmed the extracted information for all eligible studies.
RESULTS: Twenty pharmacoepidemiologic studies were eligible for data extraction. The majority of reviewed studies did not report whether the positivity assumption was checked. Six studies performed intention-to-treat analyses, but none of them reported adherence levels after treatment initiation. Eight studies chose an as-treated analytic strategy, but only one of them reported modeling the multiphase of treatment use. Almost all studies performing as-treated analyses chose the most recent treatment status as the functional form of exposure in the outcome model. Nearly half of the studies reported that the IPW estimate was substantially different from the estimate derived from a standard regression model.
CONCLUSIONS: The use of IPW method to control for time-varying confounding is increasing in medical literature. However, reporting of the application of the technique is variable and suboptimal. It may be prudent to develop best practices in reporting complex methods in epidemiologic research.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  inverse probability weighting; marginal structural models; pharmacoepidemiology

Mesh:

Year:  2014        PMID: 24458364      PMCID: PMC4043935          DOI: 10.1002/pds.3569

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  56 in total

1.  Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Authors:  Babette A Brumback; Miguel A Hernán; Sebastien J P A Haneuse; James M Robins
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

2.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

4.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

5.  The interpretation of multiplicative-model parameters as standardized parameters.

Authors:  S Greenland; G Maldonado
Journal:  Stat Med       Date:  1994-05-30       Impact factor: 2.373

6.  Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Authors:  Robert C Kalayjian; Bryan Lau; Rhoderick N Mechekano; Heidi M Crane; Benigno Rodriguez; Robert A Salata; Zipporah Krishnasami; James H Willig; Jeffrey N Martin; Richard D Moore; Joseph J Eron; Mari M Kitahata
Journal:  AIDS       Date:  2012-09-24       Impact factor: 4.177

7.  Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncompliance.

Authors:  Nancy R Cook; Stephen R Cole; Julie E Buring
Journal:  Eur J Epidemiol       Date:  2012-06-15       Impact factor: 8.082

8.  Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.

Authors:  Lauren E Cain; Stephen R Cole
Journal:  Stat Med       Date:  2009-05-30       Impact factor: 2.373

9.  Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.

Authors:  Jari Tiihonen; Jaana T Suokas; Jaana M Suvisaari; Jari Haukka; Pasi Korhonen
Journal:  Arch Gen Psychiatry       Date:  2012-05

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  15 in total

1.  The Choice of Analytical Strategies in Inverse-Probability-of-Treatment-Weighted Analysis: A Simulation Study.

Authors:  Shibing Yang; Juan Lu; Charles B Eaton; Spencer Harpe; Kate L Lapane
Journal:  Am J Epidemiol       Date:  2015-08-26       Impact factor: 4.897

2.  What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.

Authors:  S Bailly; R Pirracchio; J F Timsit
Journal:  Intensive Care Med       Date:  2015-06-24       Impact factor: 17.440

Review 3.  Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.

Authors:  Elisabetta Patorno; Elizabeth M Garry; Amanda R Patrick; Sebastian Schneeweiss; Victoria G Gillet; Olesya Zorina; Dorothee B Bartels; John D Seeger
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

4.  Launching Effectiveness Research to Guide Practice in Neurosurgery: A National Institute Neurological Disorders and Stroke Workshop Report.

Authors:  Patricia Walicke; Aviva Abosch; Anthony Asher; Fred G Barker; Zoher Ghogawala; Robert Harbaugh; Lara Jehi; John Kestle; Walter Koroshetz; Roderick Little; Donald Rubin; Alex Valadka; Stephen Wisniewski; E Antonio Chiocca
Journal:  Neurosurgery       Date:  2017-04-01       Impact factor: 4.654

5.  Daring to draw causal claims from non-randomized studies of primary care interventions.

Authors:  Nadia Sourial; Cristina Longo; Isabelle Vedel; Tibor Schuster
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

6.  Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study.

Authors:  Catherine E de Keyser; Maarten J G Leening; Silvana A Romio; J Wouter Jukema; Albert Hofman; M Arfan Ikram; Oscar H Franco; Theo Stijnen; Bruno H Stricker
Journal:  Eur J Epidemiol       Date:  2014-09-12       Impact factor: 8.082

7.  Diagnostics for Confounding of Time-varying and Other Joint Exposures.

Authors:  John W Jackson
Journal:  Epidemiology       Date:  2016-11       Impact factor: 4.822

8.  Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.

Authors:  Yaa-Hui Dong; Chia-Hsuin Chang; Li-Chiu Wu; Jing-Shiang Hwang; Sengwee Toh
Journal:  Br J Clin Pharmacol       Date:  2018-03-13       Impact factor: 4.335

9.  Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.

Authors:  Anne-Sophie Truche; Michael Darmon; Sébastien Bailly; Christophe Clec'h; Claire Dupuis; Benoit Misset; Elie Azoulay; Carole Schwebel; Lila Bouadma; Hatem Kallel; Christophe Adrie; Anne-Sylvie Dumenil; Laurent Argaud; Guillaume Marcotte; Samir Jamali; Philippe Zaoui; Virginie Laurent; Dany Goldgran-Toledano; Romain Sonneville; Bertrand Souweine; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2016-06-03       Impact factor: 17.440

10.  Missing Data in Marginal Structural Models: A Plasmode Simulation Study Comparing Multiple Imputation and Inverse Probability Weighting.

Authors:  Shao-Hsien Liu; Stavroula A Chrysanthopoulou; Qiuzhi Chang; Jacob N Hunnicutt; Kate L Lapane
Journal:  Med Care       Date:  2019-03       Impact factor: 3.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.